Literature DB >> 22494844

Design and synthesis of 4-O-methylhonokiol analogs as inhibitors of cyclooxygenase-2 (COX-2) and PGF₁ production.

Bit Lee1, Jae-Hwan Kwak, Shin-Won Huang, Jae-Yong Jang, Sanglae Lim, Young-Shin Kwak, Kiho Lee, Hyung Sook Kim, Sang-Bae Han, Jin-Tae Hong, Heesoon Lee, Sukgil Song, Seung-Yong Seo, Jae-Kyung Jung.   

Abstract

A series of novel 4-O-methylhonokiol analogs were synthesized in light of revealing structure-activity relationship for inhibitory effect of COX-2 enzyme. The key strategy of the molecular design was oriented towards modification of the potential metabolic soft spots (e.g., phenol and olefin) or by altering the polar surface area via incorporating heterocycles such as isoxazole and triazole. Most of all exhibited the inhibitory effects on COX-2 and PGF(1) production but not macrophage NO production. Especially, aryl carbamates 10 and 11 exhibited more potent inhibitory activity against COX-2 and PGF(1) production. Crown
Copyright © 2012. Published by Elsevier Ltd. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22494844     DOI: 10.1016/j.bmc.2012.03.028

Source DB:  PubMed          Journal:  Bioorg Med Chem        ISSN: 0968-0896            Impact factor:   3.641


  2 in total

1.  Methylation and Esterification of Magnolol for Ameliorating Cutaneous Targeting and Therapeutic Index by Topical Application.

Authors:  Chwan-Fwu Lin; Chi-Feng Hung; Ibrahim A Aljuffali; Yu-Ling Huang; Wei-Chun Liao; Jia-You Fang
Journal:  Pharm Res       Date:  2016-05-27       Impact factor: 4.200

2.  The new 4-O-methylhonokiol analog GS12021 inhibits inflammation and macrophage chemotaxis: role of AMP-activated protein kinase α activation.

Authors:  Sora Kim; Sun-O Ka; Youngyi Lee; Byung-Hyun Park; Xiang Fei; Jae-Kyung Jung; Seung-Yong Seo; Eun Ju Bae
Journal:  PLoS One       Date:  2015-02-23       Impact factor: 3.240

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.